Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled trial of subcutaneous allergen immunotherapy schedules in asthma sensitized to olive tree and ryegrass
2004-004317-42Phase 4Active
- Sponsor
- BIAL
- Start
- Dec 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of allergovac depot in asthma and allergic asthma (3 arms), sponsored by BIAL. Primary endpoint: Symptom score and medication use. Started Dec 2005; status: active.
02
Drugs
allergovac depot
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2004-004317-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004317-42.